ArticleCancer treatment and research communications2026
Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment.
Anamaris Torres-Sanchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.